fullerene c60 has been researched along with Escherichia coli Infections in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, P; Deng, J; Fang, L; Huang, H; Jiang, L; Li, Y; Zheng, J | 1 |
Deryabin, DG; Efremova, LV; Khakina, EA; Khakina, EE; Saidakova, EV; Sizova, EA; Troshin, PA; Vasilchenko, AS; Zhilenkov, AV | 1 |
Cho, M; Hughes, JB; Kim, JH; Snow, SD | 1 |
Chou, CK; Kanakamma, PP; Lei, HY; Luh, TY; Tsao, N | 1 |
Bai, H; Li, H; Liu, L; Ma, H; Shu, C; Wang, C; Wang, S; Xu, J; Zhang, J | 1 |
5 other study(ies) available for fullerene c60 and Escherichia coli Infections
Article | Year |
---|---|
An electrochemical immunosensor for sensitive detection of Escherichia coli O157:H7 using C60 based biocompatible platform and enzyme functionalized Pt nanochains tracing tag.
Topics: Antibodies, Immobilized; Biosensing Techniques; Chitosan; Electrochemical Techniques; Equipment Design; Escherichia coli Infections; Escherichia coli O157; Ferrous Compounds; Fullerenes; Gold; Humans; Immunoassay; Metallocenes; Models, Molecular; Nanocomposites; Platinum; Silicon Dioxide | 2013 |
A zeta potential value determines the aggregate's size of penta-substituted [60]fullerene derivatives in aqueous suspension whereas positive charge is required for toxicity against bacterial cells.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Fullerenes; Humans; Photobacterium; Static Electricity; Water | 2015 |
Escherichia coli Inactivation by UVC-Irradiated C60: kinetics and mechanisms.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Fullerenes; Humans; Kinetics; Photochemical Processes; Ultraviolet Rays | 2011 |
Inhibition of Escherichia coli-induced meningitis by carboxyfullerence.
Topics: Animals; Antiviral Agents; Blood-Brain Barrier; Brain; Carbon; Escherichia coli Infections; Female; Fullerenes; Injections, Intraperitoneal; Interleukin-1; Meningitis, Bacterial; Mice; Tumor Necrosis Factor-alpha | 1999 |
Designing an Amino-Fullerene Derivative C
Topics: Animals; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fullerenes; HEK293 Cells; Humans; Male; Rats; Rats, Wistar; Wound Healing; Wound Infection | 2019 |